Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
91 studies found for:    myalgic encephalomyelitis
Show Display Options
Rank Status Study
1 Recruiting Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
Conditions: Chronic Fatigue Syndrome;   Myalgic Encephalomyelitis;   Systemic Exertion Intolerance Disease (SEID);   Postural Tachycardia Syndrome (POTS);   Neurally Mediated Syncope (NMS)
Interventions: Drug: Normal Saline;   Dietary Supplement: Oral Rehydration Solution
2 Terminated Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Myalgic Encephalomyelitis
Intervention: Drug: Etanercept
3 Completed Behavioral Insomnia Therapy With Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Behavioral Therapy Targeted to Sleep Problems
Interventions: Behavioral: Cognitive Behavioral Therapy;   Other: Usual Care for Chronic Fatigue Syndrome (Active Control Group)
4 Unknown  The Synergy Trial: Methylphenidate Plus a CFS-Specific Nutrient Formula as a Treatment for Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome (CFS);   Myalgic Encephalomyelitis (ME)
Interventions: Drug: Methyl-P plus Nutrient Formula;   Drug: Methyl-P plus Nutrient matched placebos
5 Terminated B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Myalgic Encephalomyelitis
Intervention: Drug: Rituximab
6 Completed B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Myalgic Encephalomyelitis
Intervention: Drug: Rituximab
7 Completed The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Myalgic Encephalomyelitis
Intervention: Drug: Ampligen
8 Active, not recruiting Cyclophosphamide in Myalgic Encephalopathy/ Chronic Fatigue Syndrome (ME/CFS)
Conditions: Chronic Fatigue Syndrome (CFS);   Myalgic Encephalomyelitis (ME)
Intervention: Drug: Cyclophosphamide
9 Completed Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Fibromyalgia;   Gulf War Illness;   Multiple Chemical Sensitivity;   Interstitial Cystitis;   Irritable Bowel Syndrome
Intervention:
10 Completed Drug Intervention in Chronic Fatigue Syndrome
Condition: Chronic Fatigue Syndrome
Interventions: Drug: Rituximab;   Drug: Saline (NaCl 0,9 %) (placebo)
11 Active, not recruiting Autonomic Nervous System and Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Orthostatic Intolerance;   Postural Tachycardia Syndrome
Interventions: Other: Autonomic Function Testing;   Other: Saline infusions;   Drug: L-NMMA trimethaphan;   Drug: methyldopa
12 Terminated
Has Results
Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Orthostatic Hypotension;   Neurally Mediated Hypotension;   Neurogenic Orthostatic Hypotension
Intervention: Drug: Droxidopa
13 Completed The Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology and Intervention Trial
Conditions: Chronic Fatigue Syndrome;   Myalgic Encephalomyelitis
Interventions: Drug: Clonidine;   Drug: Lactose capsula
14 Active, not recruiting Ampligen in Chronic Fatigue Syndrome
Condition: Chronic Fatigue Syndrome
Intervention: Drug: Poly I: Poly C12U (Rintatolimod)
15 Withdrawn Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
Condition: Chronic Fatigue Syndrome
Interventions: Drug: Nutraceutical supplements;   Drug: Placebo
16 Completed Motor Control in Chronic Fatigue Syndrome and Fibromyalgia
Conditions: Fibromyalgia;   Chronic Fatigue Syndrome
Intervention:
17 Withdrawn Therapy for Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
Condition: Chronic Fatigue Syndrome
Intervention: Drug: Nutraceuticals
18 Unknown  Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome
Condition: Chronic Fatigue Syndrome
Intervention:
19 Completed Cytokine Inhibition in Chronic Fatigue Syndrome Patients
Condition: Chronic Fatigue Syndrome
Interventions: Drug: Anakinra;   Drug: Placebo
20 Active, not recruiting Coping With Chronic Fatigue Syndrome: Development of a Community-based Patient Education Program
Conditions: Chronic Fatigue Syndrome;   Coping;   Patient Education
Intervention: Behavioral: Patient education program

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years